Trial intelligence / Profile preview

Aromatase inhibitor plus or minus saracatinib in postmenopausal women with advanced breast cancer

2011-002157-64Phase 2Completed

Sponsor
NHS National Services Scotland
Start
Feb 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of saracatinib in breast cancer, sponsored by NHS National Services Scotland. Started Feb 2012; status: completed.

02

Drugs

saracatinib
03

Conditions

breast cancer

Beyond the preview

Go deeper on 2011-002157-64.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002157-64.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call